Hogy Medical Co.,Ltd.

Hogy Medical Co.,Ltd.

HGYMF
Hogy Medical Co.,Ltd.US flagOther OTC
34.99
USD
- -
- -
754.37MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1,051.96
1,105.99
1,120
1,162.47
1,175.52
1,178.96
1,203
1,232.65
1,207.47
1,287.58
1,607
1,611.55
1,750.4
806.29
Basic EPS, GAAP
166.79
179.03
179.89
187.87
184.53
168.04
198.31
183.05
164.03
152.99
177.93
115.57
67.98
44.18
Free Cash Flow per Basic Share
140.75
226.84
-122.58
-285.31
134.68
137
181.61
5
-22.69
185.55
320.9
177.89
279.43
164.19
Dividend per Share
48.51
53.44
55.47
57.51
59.73
61.79
64.06
65.68
67.61
69.84
69.96
77.98
81.98
40.02
Book Value per Share
2,021.49
2,147.11
2,271.54
2,402.03
2,534.63
2,644.28
2,851.56
2,991.46
3,085.24
3,348.53
4,050.99
3,086.47
2,847.78
2,673.96
Tangible Book Value per Share
2,161.38
2,338.47
2,567.49
2,682
2,759.54
2,909.17
2,914.24
3,033.28
3,109.32
2,746.78
3,415.88
3,529.05
3,307.5
3,106.41
Basic Weighted Avg Shares
31
31
31
31
31
31
30
30
30
29
24
24
22
24
Sales/Revenue/Turnover
33,094
34,793
35,233
36,568
36,859
36,918
36,658
37,232
36,504
36,778
38,981
39,100
39,138
19,564
Operating Margin (%)
24.52
25.14
24.14
24.02
20.19
14.28
11.96
14.26
15.43
16.68
17.02
10.66
9.74
9.17
Depreciation Expense
2,971
2,865
2,708
3,376
4,409
6,235
5,631
5,283
4,549
4,115
3,617
6,607
5,741
3,312
Net Income, GAAP
5,247
5,632
5,659
5,910
5,786
5,262
6,043
5,529
4,959
4,370
4,316
2,804
1,520
1,072
Effective Tax Rate (%)
37.18
36.6
34.79
32.39
31.3
30.61
28.9
28.93
29.47
31.04
30.76
31.46
48.16
35.68
Profit Margin (%)
15.85
16.19
16.06
16.16
15.7
14.25
16.48
14.85
13.58
11.88
11.07
7.17
3.88
5.48
Working Capital
33,726
34,201
26,243
24,512
26,932
34,053
34,921
32,869
33,732
25,942
29,156
34,784
33,819
36,028
LT Debt
- -
- -
- -
- -
508
399
285
175
- -
7,667
5,668
3,669
11,670
12,669
Total Equity
69,601
75,379
83,300
87,609
89,628
94,063
91,403
93,920
95,951
79,994
83,678
86,118
74,331
75,798
Return on Invested Capital (%)
7.42
7.46
6.58
6.56
5.61
3.89
3.28
3.97
4.11
4.49
4.97
3.08
2.18
1.25
Return on Capital (%)
8.45
8.55
7.78
7.65
7.34
6.4
7.02
6.2
5.4
4.42
4.1
3.01
1.97
1.34
Return on Common Equity (%)
8.5
8.59
8.14
8.04
7.46
6.49
7.12
6.24
5.4
4.63
4.45
3.24
2.19
1.54

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
2,154
- -
1,999
LT Borrowings
3,669
- -
12,669
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
24
- -
22
Market Capitalization
90,371
95,073
84,892

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
43,025
- -
45,332
Cash, Cash Equivalents & STI
19,419
- -
22,664
Accounts Receivable, Net
8,458
- -
7,690
Inventories
9,455
- -
9,979
Total Current Liabilities
8,241
- -
9,304
Payables & Accruals
- -
- -
- -
ST Debt
2,154
- -
1,999
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.83%
-4.13%
-13.69%
Free Cash Flow
-146.08%
-275.96%
44.76%
Net Income, GAAP
-10.46%
-20.85%
-45.79%
Sales/Revenue/Turnover
1.08%
1.04%
0.1%
Total Cash Common Dividend
0.71%
-1.19%
-3.12%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9,679
9,857
10,218
9,346
39,100
2025
- -
- -
- -
- -
39,138
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
36.53
- -
- -
- -
115.57
2025
- -
- -
- -
- -
67.98
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
17.97
- -
- -
- -
77.98
2025
- -
- -
- -
- -
81.98
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Hideki Kawakubo
Full Time Employees
1,408
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
7-7, Akasaka 2-chome Tokyo Japan 107-8615
IPO Date
Dec 2, 2014
Website
hogy.co.jp
Business
Hogy Medical Co., Ltd. manufactures and sells medical consumables, non-woven fabric products, surgical kits, and related equipment primarily in Japan. Founded in 1961 and headquartered in Tokyo, the company offers premium surgical kits including all-in-one pre-, mid-, and post-surgery solutions; non-woven products such as gowns, drapes, personal protective equipment, instrument table covers, wraps, and Tigalyer liquid-barrier fabric; sterilization products comprising Mekkin Bags pouches, hybrid Mekkin Bags ID layered type, autoclave forceps stands, Mekkin cards, ethylene oxide gas cards, and indicator tapes; and medical equipment like Opera Master surgery management system, ME equipment operation management system, narcotics/poisons box with RFID, endoscope holders, Securea polyurethane sponge for endoscopic surgery, REVICE, and hospital masks. It operates through subsidiaries including P.T. Hogy Indonesia for sales in Indonesia and ASEAN markets such as Singapore. Recent developments include a sales collaboration agreement with Covidien Japan, Inc. in 2024 for SuReFInD R-SUDs lung resection technology integrated with Endo GIA staplers; a business acquisition on August 1, 2025, to bolster digital products like the medical smart recorder OPeDrive; launches of Flowtron, Trocar E, and expansions in trocars, gynecology, cardiac surgery products, energy devices, and endoscopic products under a new medium-term plan targeting March 2030; and consideration of strategic options including potential privatization announced in July 2025 amid downward earnings revisions for fiscal year ending March 2026 due to business challenges.